Approval of in vitro diagnostic devices

Introduction

In vitro diagnostic (IVD) devices are medical devices used to examine samples collected from the human body, such as blood, urine, tissue and saliva, outside the human body. These devices help detect diseases, identify infections, monitor medical conditions and support treatment decisions. Examples include pregnancy test kits, blood glucose meters, HIV diagnostic kits, clinical laboratory reagents and molecular diagnostic systems.

Approval of IVD devices is an important part of medical device regulation because inaccurate diagnostic results may lead to incorrect treatment, delayed diagnosis or serious health consequences. Regulatory authorities therefore establish requirements relating to safety, quality, performance, manufacturing standards and clinical evidence before such devices are introduced into the market.

Meaning and importance of IVD approval

IVD approval refers to the regulatory process through which an authorised government authority evaluates whether an in vitro diagnostic device satisfies applicable legal and technical requirements.

The approval process generally examines:

Analytical performance: Whether the device accurately detects or measures the intended biological substance.

Clinical performance: Whether the test produces clinically meaningful results in the intended patient population.

Safety: Whether the device presents unacceptable risks to patients, healthcare professionals or laboratory personnel.

Quality management: Whether manufacturing processes consistently produce reliable devices.

Labelling and instructions: Whether the intended purpose, limitations, warnings and operating instructions are clearly communicated.

Post-market surveillance: Whether manufacturers monitor device performance and report relevant safety incidents after commercialisation.

The objective is to ensure that diagnostic devices provide reliable results and do not expose patients to avoidable medical risks.

Legal framework governing IVD approval in India

India regulates IVD devices primarily through the Drugs and Cosmetics Act, 1940, and the Medical Devices Rules, 2017.

The Medical Devices Rules, 2017, provide a specific regulatory framework for medical devices, including in vitro diagnostic medical devices.

1. Classification of IVD devices

IVDs are classified according to their intended purpose and the risk associated with incorrect diagnostic results. The classification system includes four categories:

Class A: Low-risk devices.

Class B: Low-moderate-risk devices.

Class C: Moderate-high-risk devices.

Class D: High-risk devices.

For example, certain general laboratory reagents may fall into lower-risk categories, while diagnostic tests for serious infectious diseases or blood-screening purposes may fall into higher-risk categories, depending on their intended use and applicable classification rules.

2. Regulatory authorities

The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India, plays a major role in regulating medical devices.

The regulatory responsibilities are distributed according to the applicable device classification and licensing provisions. The Central Licensing Authority and State Licensing Authorities perform functions assigned under the Medical Devices Rules.

3. Licensing and manufacturing requirements

Manufacturers must obtain the applicable manufacturing licence or registration before undertaking regulated commercial activities. Importers must also comply with the relevant import authorisation requirements.

Applicants generally need to provide:

Device description and intended purpose.

Classification and risk assessment.

Analytical and clinical performance evidence, as applicable.

Manufacturing and quality-management information.

Labelling and instructions for use.

Stability and safety information.

Details of manufacturing facilities.

4. Quality and performance standards

IVD manufacturers must comply with applicable quality-management and performance requirements. ISO 13485 is an important internationally recognised quality-management standard for medical device manufacturers.

ISO 14971 provides a framework for medical device risk management. Compliance with relevant standards may support regulatory submissions, subject to applicable Indian requirements.

Approval process for IVD devices

The approval process generally involves several stages.

First, device classification: The manufacturer identifies the appropriate risk class based on the intended purpose and classification rules.

Second, technical documentation: The applicant prepares information about the device's design, materials, manufacturing process, performance and safety.

Third, performance evaluation: Analytical and clinical performance evidence is generated to demonstrate that the device performs as intended.

Fourth, regulatory application: The manufacturer or authorised applicant submits the relevant application and supporting documents to the appropriate licensing authority.

Fifth, regulatory assessment: The authority examines the submitted information and may inspect the manufacturing facility or request additional evidence.

Finally, licensing and post-market monitoring: If applicable requirements are satisfied, the relevant licence or permission may be granted. Manufacturers must continue monitoring device performance and complying with reporting and other post-market obligations.

Important case laws

Direct Indian Supreme Court decisions specifically concerning approval of IVD devices are limited. However, several judgments provide important principles relevant to medical device regulation, product safety and regulatory decision-making.

1. Medtronic Inc. v. Mirowski Family Ventures, LLC (2014)

The US Supreme Court considered a dispute involving medical technology patents and the allocation of the burden of proof in a declaratory judgment action.

Legal significance: Although it was not an IVD approval case, it illustrates the legal importance of medical technology innovation and the relationship between regulatory and intellectual property issues.

2. Boston Scientific Medizintechnik GmbH v. AOK Sachsen-Anhalt (Joined Cases C-503/13 and C-504/13, 2015)

The Court of Justice of the European Union examined product safety and defect-related issues involving implanted medical devices.

Legal significance: The judgment demonstrates the importance of identifying safety risks associated with medical devices and taking appropriate regulatory and corrective measures. Its principles are relevant by analogy to diagnostic devices where product reliability is essential.

3. Commission v. France (Case C-419/03, 2007)

The Court of Justice of the European Union considered regulatory requirements concerning medical devices and the obligations associated with their lawful marketing.

Legal significance: The decision illustrates the importance of compliance with the European medical device regulatory framework. It is relevant as comparative authority, although it does not establish India's IVD approval procedure.

4. Indian Medical Association v. V.P. Shantha (1995)

The Supreme Court of India examined the applicability of consumer protection law to medical services.

Legal significance: The judgment is relevant because inaccurate diagnostic services may raise consumer protection issues where deficiencies in medical services cause harm. It does not directly decide licensing requirements for IVD manufacturers.

Challenges in IVD regulation

IVD regulation faces several challenges because diagnostic technologies are developing rapidly. Molecular diagnostics, genetic testing, artificial intelligence-based interpretation and point-of-care testing require specialised performance evaluation.

Important challenges include:

Inaccurate or inconsistent test results.

Limited clinical validation data.

Manufacturing quality-control failures.

Inadequate instructions and diagnostic limitations.

Counterfeit or unauthorised diagnostic products.

Difficulties in monitoring devices after market approval.

Regulatory delays involving innovative diagnostic technologies.

Regulatory authorities must maintain a balance between encouraging scientific innovation and protecting public health.

Conclusion

Approval of in vitro diagnostic devices is essential for ensuring reliable disease detection, patient safety and public confidence in diagnostic technologies. In India, the Drugs and Cosmetics Act, 1940, and the Medical Devices Rules, 2017, provide the principal regulatory framework for the classification, licensing, performance evaluation and monitoring of IVD devices.

Although the cited judicial decisions do not directly establish a comprehensive legal test for IVD approval, they provide relevant principles concerning medical technology, product safety and consumer protection. Effective regulation requires scientific validation, proper licensing, quality management and continuous post-market surveillance to ensure that diagnostic devices remain safe and reliable.